ATE426662T1 - Feedback resistante mevalonate kinase - Google Patents
Feedback resistante mevalonate kinaseInfo
- Publication number
- ATE426662T1 ATE426662T1 AT04736497T AT04736497T ATE426662T1 AT E426662 T1 ATE426662 T1 AT E426662T1 AT 04736497 T AT04736497 T AT 04736497T AT 04736497 T AT04736497 T AT 04736497T AT E426662 T1 ATE426662 T1 AT E426662T1
- Authority
- AT
- Austria
- Prior art keywords
- mevalonate kinase
- feedback resistant
- resistant mevalonate
- vectors
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03012294 | 2003-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE426662T1 true ATE426662T1 (de) | 2009-04-15 |
Family
ID=33547583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04736497T ATE426662T1 (de) | 2003-06-12 | 2004-06-10 | Feedback resistante mevalonate kinase |
Country Status (9)
Country | Link |
---|---|
US (1) | US7422884B2 (de) |
EP (1) | EP1631664B1 (de) |
JP (1) | JP4643569B2 (de) |
KR (1) | KR101190897B1 (de) |
CN (1) | CN1806042B (de) |
AT (1) | ATE426662T1 (de) |
DE (1) | DE602004020218D1 (de) |
ES (1) | ES2323175T3 (de) |
WO (1) | WO2004111214A1 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4841562B2 (ja) * | 2004-12-14 | 2011-12-21 | ディーエスエム アイピー アセッツ ビー.ブイ. | 改良型メバロネートキナーゼ |
KR101482081B1 (ko) | 2005-03-18 | 2015-01-13 | 마이크로비아 인크. | 유질 효모와 진균 내에서 카로티노이드의 생산 |
WO2008039499A2 (en) | 2006-09-26 | 2008-04-03 | The Regents Of The University Of California | Production of isoprenoids and isoprenoid precursors |
EP2078092A2 (de) | 2006-09-28 | 2009-07-15 | Microbia, Inc. | Herstellung von carotenoiden in öliger hefe und pilzen |
JP2009000046A (ja) * | 2007-06-21 | 2009-01-08 | Hitachi Zosen Corp | トチュウのメバロン酸経路の酵素をコードする遺伝子 |
SG162265A1 (en) | 2007-12-13 | 2010-07-29 | Danisco Us Inc | Compositions and methods for producing isoprene |
MX2010011706A (es) | 2008-04-23 | 2011-03-15 | Danisco Us Inc | Variantes de isopreno-sintasa para produccion microbiana mejorada de isopreno. |
EP2157174A1 (de) | 2008-08-12 | 2010-02-24 | DSM IP Assets B.V. | Erhöhte Produktion von Pantothenate (Vitamin B5) |
MY156562A (en) | 2008-09-15 | 2016-02-26 | Danisco Us Inc | Increased isoprene production using the archaeal lower mevalonate pathway |
WO2010124146A2 (en) | 2009-04-23 | 2010-10-28 | Danisco Us Inc. | Three-dimensional structure of isoprene synthase and its use thereof for generating variants |
EP2336310A1 (de) | 2009-12-16 | 2011-06-22 | Isobionics B.V. | Valencensynthase |
CN103179850B (zh) | 2010-06-02 | 2016-03-16 | 沃维公司 | 甜菊糖苷的重组生产 |
WO2012014228A1 (en) | 2010-07-28 | 2012-02-02 | Abhishek Narain Singh | A method to by-pass allosteric domain activity of an enzyme so as to alter its feedback or feed-forward inhibition or activation |
US20120045812A1 (en) * | 2010-08-06 | 2012-02-23 | Danisco Us Inc. | PRODUCTION OF ISOPRENE UNDER NEUTRAL pH CONDITIONS |
JP2014502148A (ja) | 2010-10-27 | 2014-01-30 | ダニスコ・ユーエス・インク | イソプレン生産の向上を目的としたイソプレン合成酵素変異体 |
WO2012175574A1 (en) | 2011-06-21 | 2012-12-27 | Dsm Ip Assets B.V. | Increased pantothenate (vitamin b5) production |
EP2537926A1 (de) | 2011-06-21 | 2012-12-26 | Isobionics B.V. | Valencensynthase |
WO2012175575A2 (en) | 2011-06-21 | 2012-12-27 | Dsm Ip Assets B.V. | Increased vitamin b5 production |
WO2013022799A1 (en) | 2011-08-05 | 2013-02-14 | Danisco Us Inc. | PRODUCTION OF ISOPRENOIDS UNDER NEUTRAL pH CONDITIONS |
CN103732753B (zh) | 2011-08-08 | 2018-03-30 | 埃沃尔瓦公司 | 甜菊醇糖苷类的重组生产 |
CN103205432B (zh) * | 2012-01-11 | 2015-06-10 | 安徽医科大学第一附属医院 | 弥散型浅表性光线性汗孔角化症(dsap)相关基因 |
US9163263B2 (en) | 2012-05-02 | 2015-10-20 | The Goodyear Tire & Rubber Company | Identification of isoprene synthase variants with improved properties for the production of isoprene |
JP6379112B2 (ja) | 2013-02-06 | 2018-08-22 | エヴォルヴァ エスアー.Evolva Sa. | レバウディオサイドdおよびレバウディオサイドmの改良された産生方法 |
AU2014213918B2 (en) | 2013-02-11 | 2017-11-09 | Danstar Ferment Ag | Efficient production of steviol glycosides in recombinant hosts |
RU2014112066A (ru) | 2014-03-28 | 2015-10-10 | Адзиномото Ко., Инк. | Способ получения мономерного изопрена |
BR112017002783A2 (pt) | 2014-08-11 | 2017-12-19 | Evolva Sa | produção de glicosídeos de esteviol em hospedeiros recombinantes |
KR20170052647A (ko) | 2014-09-09 | 2017-05-12 | 에볼바 에스아 | 재조합 숙주에서 스테비올 글리코시드의 생성 |
BR112017016338A2 (pt) | 2015-01-30 | 2018-03-27 | Evolva Sa | produção de glicosídeos de esteviol em hospedeiros recombinantes |
EP3862426A3 (de) | 2015-03-16 | 2021-11-17 | DSM IP Assets B.V. | Udp-glycosyltransferasen |
CA2995067A1 (en) | 2015-08-07 | 2017-02-16 | Evolva Sa | Production of steviol glycosides in recombinant hosts |
CA3020671A1 (en) | 2016-04-13 | 2017-10-19 | Evolva Sa | Production of steviol glycosides in recombinant hosts |
WO2017198682A1 (en) | 2016-05-16 | 2017-11-23 | Evolva Sa | Production of steviol glycosides in recombinant hosts |
CN110100006A (zh) | 2016-11-07 | 2019-08-06 | 埃沃尔瓦公司 | 重组宿主中甜菊糖苷的生产 |
NL2018457B1 (en) | 2017-03-02 | 2018-09-21 | Isobionics B V | Santalene Synthase |
NL2019473B1 (en) | 2017-09-01 | 2019-03-11 | Isobionics B V | Terpene Synthase producing patchoulol and elemol, and preferably also pogostol |
KR102092075B1 (ko) * | 2017-10-27 | 2020-03-23 | 경상대학교산학협력단 | MmMVK-메발론산 복합체의 3차원 결정 구조 및 기질저해 저항성 돌연변이 메발론산 인산화효소 |
WO2019113387A1 (en) | 2017-12-07 | 2019-06-13 | Zymergen Inc. | Engineered biosynthetic pathways for production of (6e)-8-hydroxygeraniol by fermentation |
JP2021506316A (ja) | 2017-12-21 | 2021-02-22 | ザイマージェン インコーポレイテッド | ネペタラクトールオキシドレダクターゼ、ネペタラクトールシンターゼ、及びネペタラクトンを産生する能力がある微生物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI250210B (en) | 1998-05-06 | 2006-03-01 | Dsm Ip Assets Bv | An isolated DNA sequence coding for an enzyme involved in the mevalonate pathway or the pathway from isopentenyl pyrophosphate to farnesyl pyrophosphate |
ES2311613T3 (es) | 2001-06-06 | 2009-02-16 | Dsm Ip Assets B.V. | Produccion mejorada de isoprenoides. |
-
2004
- 2004-06-10 KR KR1020057023857A patent/KR101190897B1/ko active IP Right Grant
- 2004-06-10 US US10/560,726 patent/US7422884B2/en not_active Expired - Lifetime
- 2004-06-10 AT AT04736497T patent/ATE426662T1/de not_active IP Right Cessation
- 2004-06-10 ES ES04736497T patent/ES2323175T3/es not_active Expired - Lifetime
- 2004-06-10 DE DE602004020218T patent/DE602004020218D1/de not_active Expired - Lifetime
- 2004-06-10 WO PCT/CH2004/000353 patent/WO2004111214A1/en active Search and Examination
- 2004-06-10 JP JP2006515622A patent/JP4643569B2/ja not_active Expired - Fee Related
- 2004-06-10 CN CN2004800163840A patent/CN1806042B/zh not_active Expired - Fee Related
- 2004-06-10 EP EP04736497A patent/EP1631664B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4643569B2 (ja) | 2011-03-02 |
KR101190897B1 (ko) | 2012-10-12 |
US7422884B2 (en) | 2008-09-09 |
WO2004111214A1 (en) | 2004-12-23 |
JP2007523612A (ja) | 2007-08-23 |
US20070141685A1 (en) | 2007-06-21 |
DE602004020218D1 (de) | 2009-05-07 |
EP1631664B1 (de) | 2009-03-25 |
EP1631664A1 (de) | 2006-03-08 |
CN1806042B (zh) | 2012-07-04 |
KR20060022692A (ko) | 2006-03-10 |
ES2323175T3 (es) | 2009-07-08 |
CN1806042A (zh) | 2006-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE426662T1 (de) | Feedback resistante mevalonate kinase | |
ATE500321T1 (de) | Verbesserte mevalonatkinase | |
HK1071572A1 (en) | PyrazoloÄ1,5-AÜpyrimidine compounds as cyclin dependent kinase inhibitors | |
AU2003221753A1 (en) | Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors | |
TW200736231A (en) | Substituted pyrimidines | |
WO2005084305A3 (en) | Flavonoids | |
NO20082482L (no) | Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer | |
WO2008033408A3 (en) | Methods for identifying compounds that modulate cell signaling and methods employing such compounds | |
TW200604184A (en) | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors | |
HK1080843A1 (en) | (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors | |
TW200731094A (en) | Extensible meta-data | |
BR0315233A (pt) | Derivados de azaindol como inibidores de p38 cinase | |
ATE297395T1 (de) | 3-(pyrolyllacton)-2-indolinon verbindungen zur verwendung als kinase-hemmstoffe | |
DE60323749D1 (de) | Substituierte pyrroline als kinase inhibitoren | |
CY1108092T1 (el) | Ενωσεις και μεθοδοι για την αναστολη της μιτωτικης προοδου με την αναστολη της κινασης aurora | |
MXPA06003297A (es) | Metodo de servicio de certificacion segura. | |
MY146989A (en) | Kinase inhibitors | |
DE602005023333D1 (de) | Kinaseinhibitoren | |
NO20053395L (no) | Framgangsmate for styring av prosess i borehull, bruk av seismisk kommunikasjon. | |
WO2009054939A8 (en) | Cancer classification and methods of use | |
WO2004043379A3 (en) | Chemical compounds | |
TNSN06099A1 (en) | Coding system for security documents | |
EP1605264A4 (de) | Integrierender analysechip mit minimierten reaktoren und dessen anwendung | |
WO2002066681A3 (en) | Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors | |
WO2023177356A3 (en) | Compounds and method for pkmyt1 inhibition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |